Navigation Links
MO BIO Laboratories, Inc. Launches PowerBiofilm(TM) DNA and RNA Isolation Kits
Date:3/2/2010

CARLSBAD, Calif., March 2 /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in soil, water and microbial nucleic acid purification, announces the launch of two innovative new products, PowerBiofilm™ DNA Isolation Kit and PowerBiofilm™ RNA Isolation Kit. The PowerBiofilm™ kits are designed to isolate high-quality DNA or RNA from virtually any type of biofilm sample, from dental plaque to microbial mats.  Biofilms are a ubiquitous form of microbial life in natural, industrial and hospital settings with far reaching impacts from infectious disease to bioremediation.  As research on the unique characteristics of biofilms increases, PowerBiofilm™ kits are expected to become valuable tools for biofilm microbial community analysis and metagenomics.  

The PowerBiofilm™ DNA and RNA Isolation kits are the first commercial kits designed to isolate nucleic acids from the wide range of biofilm samples. These kits include a brand new bead tube mix which combines both mechanical and chemical cell lysis for optimal penetration of polymeric substances commonly found in biofilms.  The kits also contain our patented Inhibitor Removal Technology® (IRT) for better sensitivity in PCR, RT-PCR or sequencing and it yields nucleic acids of high quality and purity.  With IRT, even biofilms containing heavy amounts of contaminants can be processed to provide inhibitor-free DNA and RNA.  

The PowerBiofilm™ DNA and RNA Isolation Kits are available now.  For more information visit the MO BIO website (www.mobio.com/biofilm) or call 800-606-6246 to order.

MO BIO Laboratories, Inc. (www.mobio.com) has developed innovative tools for researchers in Molecular Biology since 1993.  A global leader in solutions for soil and microbial nucleic acid purification, MO BIO's Power® kits contain patented Inhibitor Removal Technology® for removal of PCR inhibiting substances during the nucleic acid purification procedure. For samples that do not require inhibitor removal, MO BIO's UltraClean® line includes optimized products for DNA and RNA isolation from a variety of sample types. Also for clinical samples, the BiOstic™ kits provide solutions for higher yields and purity of nucleic acids. At MO BIO Laboratories, Inc., our focus is quality products that work, save time and function for all sample types, not just the easy ones.  It is MO BIO's aim to make researchers' working lives more productive and efficient, creating time to focus on what is critical, not just in work, but in life.  

SOURCE MO BIO Laboratories, Inc.

Back to top

RELATED LINKS
http://www.mobio.com

'/>"/>

SOURCE MO BIO Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MO BIO Laboratories, Inc. Launches PowerWater(R) RNA Isolation Kit
2. DermTech and Stiefel Laboratories, Inc. to Further Evaluate EGIR(TM) Technology
3. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets
4. Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents
5. Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108
6. Roxane Laboratories, Inc. Announces the Launch of Mycophenolate Mofetil 250mg Capsules and 500mg Tablets
7. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
8. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009
9. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
10. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings
11. Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... (NASDAQ: VWR), the leading global independent provider of product and ... financial results for the fourth quarter and full year ended ... 4Q16 record quarterly net sales of $1.13 billion, up 1.6% ... 4Q16 EMEA-APAC segment net sales increased 0.4%, ... sales increased 2.5%, or down 0.9% on an organic basis, ...
(Date:2/23/2017)... - The Fight Against Cancer Innovation Trust (FACIT) and ... to report that Fusion Pharmaceuticals Inc. (Fusion) has closed ... Innovation – JJDC, Inc. (JJDC) as the lead investor. ... Partners, and Genesys Capital, as well as founding investor ... ...
(Date:2/23/2017)... ... February 23, 2017 , ... Brain ... to begin marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting ... in healthcare facilities during periods of rest. A lightweight, non-invasive monitor is placed ...
(Date:2/23/2017)... Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing biological therapies ... Marbán, Ph.D, president and chief executive officer, is scheduled to ... Cowen and Company 37th Annual Health Care Conference Tuesday, March ... 29th Annual ROTH Conference Tuesday, ... Dana Point, CA ...
Breaking Biology Technology:
(Date:2/14/2017)... 14, 2017  Wake Forest Baptist Medical Center today ... chief executive officer (CEO). Freischlag joins the medical center ... McConnell , M.D., who last year announced that he ... Center, after leading it since 2008.   ... Wake Forest Baptist,s academic health system, which includes Wake ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):